Hilbert Investment Solutions Appoints François Zagamé as Head of Research
London and Paris - Specialist structured product firm Hilbert Investment Solutions has appointed François Zagamé as Head of Research in the UK.
François started his career at AIG Global Investment Group as an Equity Research Analyst/Portfolio Manager, followed by investment research positions at UBS Wealth Management and Insight Investment. He joined Old Mutual subsidiary Skandia Investment Group in 2007 as Head of Global and UK Equity Research before moving into Portfolio Management at the group in 2009.
François holds an MBA from the London Business School. He has joined Hilbert to ensure that both its direct and third-party investment processes are robust and cater to its clients’ investment goals.
Hilbert’s founder Steve Lamarque said “We decided to increase our Equity Research resources by creating a dedicated Research Unit to support Hilbert’s product design team. François brings with him nearly 25 years of investment experience and will help strengthen our research capabilities allowing us to design structured products tailor-made for our clients.”
Notes to editors
About Hilbert Investment Solutions
The firm was established in 2012 by former Old Mutual head of structured products Steve Lamarque to specialise in cross asset, structured solutions covering equities, rates and commodities.
Hilbert specialises in innovative, forward-looking investment solutions, often tailored to individual client needs. The team can design structures to meet a specific performance target, match a particular appetite for risk or satisfy environmental or social responsibility expectations.
Hilbert believes that delivery is just as important as structuring, with ongoing client support including high quality research which enables distributors to explain the rationale behind the tools and ideas and how they fit within investment portfolios.
In 2016, Hilbert joined the UK Structured Products Association and aligned itself to the UKSPA Code and utilises its product risk rating regime.